UAE FIBROID Results Show Improvement, No Device Differences
This article was originally published in The Gray Sheet
Executive Summary
Initial results of patients treated with uterine artery embolization (UAE) in the FIBROID registry show significant improvements in symptoms and quality of life, but reveal no differences in outcome among the various device brands studied